XML 60 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share - Summary (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Numerator:        
Net loss attributable to Surgery Partners, Inc. $ (22.9) $ (61.6) $ (70.8) $ (121.6)
Less: Amounts attributable to participating securities 0.0 (10.0) (10.3) (29.2)
Net loss attributable to common stockholders $ (22.9) $ (71.6) $ (81.1) $ (150.8)
Denominator:        
Weighted average shares outstanding- basic (shares) 80,726 48,883 68,350 48,736
Weighted average shares outstanding- diluted (shares) [1] 80,726 48,883 68,350 48,736
Loss per share:        
Basic (in USD per share) $ (0.28) $ (1.46) $ (1.19) $ (3.09)
Diluted (in USD per share) [1] $ (0.28) $ (1.46) $ (1.19) $ (3.09)
Stock options        
Loss per share:        
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares) 1,974 810 1,927 285
Restricted shares        
Loss per share:        
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares) 1,461 986 1,444 848
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.